Compare
BGF World Healthscience C2 Cap EUR LU0331289677
Asset allocation
| Foreign stocks | 97.75% |
| Other | 2.25% |
| Total NAV | 253.35 mln (Euro) |
Update date: 3/31/2026
Currency allocation
| United States Dollar | 75.26% |
| Swiss Franc | 11.10% |
| British Pound | 6.65% |
| Euro | 4.68% |
| Danish Krone | 1.65% |
| Japanese Yen | 0.86% |
| Non definito | -0.20% |
Update date: 3/31/2026
Geographical allocation
| North America | 69.62% |
| Europe | 28.48% |
| Africa, Arabic Area, Middle East | 1.22% |
| Asia Pacific | 0.88% |
| World / Multiple areas | -0.20% |
Update date: 3/31/2026
Sector allocation
| Health Care | 91.30% |
| INDUSTRIALS | 5.17% |
| Not Available | 3.22% |
| INFORMATION TECHNOLOGY | 0.27% |
| FINANCIALS | 0.05% |
Update date: 3/31/2026
Top Ten holdings
| ELI LILLY | 7.97% |
| ASTRAZENECA PLC | 5.68% |
| ABBVIE INC | 4.57% |
| NOVARTIS AG | 4.43% |
| MERCK & CO INC | 4.41% |
| ROCHE PS PAR AG | 4.34% |
| GILEAD SCIENCES INC | 3.50% |
| UNITEDHEALTH GROUP INC | 2.87% |
| AMGEN INC | 2.79% |
| BLK ICS USD LIQ AGENCY DIS | 2.45% |
Update date: 3/31/2026